Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

American Health Packaging: Desmopressin Acetate Tablets Recalled for Missing Desiccant

Agency Publication Date: February 18, 2020
Share:
Sign in to monitor this recall

Summary

American Health Packaging is recalling 5,599 cartons of Desmopressin Acetate Tablets (0.1 mg and 0.2 mg) because the product bottles may be missing a desiccant, which is a small packet used to keep the medication dry. This defect occurred due to manufacturing deviations from Good Manufacturing Practices. Without the desiccant, moisture could potentially affect the stability and effectiveness of the medication over time.

Risk

The absence of a desiccant packet in the bottle may expose the tablets to moisture, which can cause the medication to degrade or lose its potency before its expiration date. This could result in patients receiving a less effective dose of their prescribed medication.

What You Should Do

  1. Check your medication packaging for Desmopressin Acetate Tablets, 0.1 mg (NDC 68084-606-21) with lot number 181109 and expiration date 4/30/2020.
  2. Check your medication packaging for Desmopressin Acetate Tablets, 0.2 mg (NDC 68084-604-21) with lot numbers 180510 (Exp 3/31/2020) or 181912 (Exp 4/30/2020).
  3. Contact your healthcare provider or pharmacist immediately to determine if your medication is affected and to discuss if a replacement is necessary.
  4. Return any unused product from the affected lots to your pharmacy to receive a refund.
  5. Contact American Health Packaging for further instructions regarding this recall.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA).

Your Remedy Options

๐Ÿ’ฐFull Refund

Contact healthcare provider and return to pharmacy.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Desmopressin Acetate Tablets, 0.1 mg, 30 tablets (3 x 10 unit dose blister cards)
Model:
NDC Carton: 68084-606-21
NDC Unit Dose: 68084-606-11
Lot Numbers:
181109 (Exp 4/30/2020)
Date Ranges: Exp 4/30/2020
Product: Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards)
Model:
NDC Carton: 68084-604-21
NDC Unit Dose: 68084-604-11
Lot Numbers:
180510 (Exp 3/31/2020)
181912 (Exp 4/30/2020)
Date Ranges: Exp 3/31/2020, Exp 4/30/2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 84990
Status: Resolved
Manufacturer: American Health Packaging
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 2 products (1,879 cartons; 3,720 cartons)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.